Bogart Wealth LLC’s Corcept Therapeutics CORT Stock Holding History

Bogart Wealth LLC’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7	Closed	-$244	–	1844
2025 Q4	$244	Hold	7	–	–	﹤0.01%	1530
2025 Q3	$582	Buy	+7	New	+$507	﹤0.01%	1374

Other funds holding CORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bogart Wealth LLC's CORT Position: Q1 2026 in Review

Bogart Wealth LLC sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 7 shares — an estimated $244 sold.

Bogart Wealth LLC first reported a position in CORT in Q3 2025 and held it in 2 quarters. The position peaked at $582 in Q3 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

Bogart Wealth LLC reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
Bogart Wealth LLC sold 7 Corcept Therapeutics shares in Q1 2026, an estimated $244.
Bogart Wealth LLC first reported a position in Corcept Therapeutics in Q3 2025 and held it in 2 quarters.
Bogart Wealth LLC's Corcept Therapeutics position peaked at $582 in Q3 2025.
351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.